Eisai Brings Tailored Information to People Living with Cancer Through Online Nursing Resource

NSider^® Patient Education Tool Developed by Nurses Experienced in Cancer

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eisai Inc. today announced the launch of the NSider^® Patient Education Tool, an online program that provides patients and caregivers individualized information about living with cancer. NSider was created by Eisai and a team of oncology nurses who have in-depth professional, and for some, personal experience with cancer. Nurses can access the site to assemble information for their patients at http://www.nsidernurses.com.

“Educating our patients about cancer is one of the most important things we do, but as a cancer survivor I know that the sheer volume of information available to patients can feel overwhelming and impersonal”

“Educating our patients about cancer is one of the most important things we do, but as a cancer survivor I know that the sheer volume of information available to patients can feel overwhelming and impersonal,” said Katie Sargent, R.N., hematology nurse clinician at Indiana University Simon Cancer Center in Indianapolis and member of the NSider steering committee. “NSider helps make it possible for patients to receive educational material tailored just for them, based on their individual needs and challenges.”

The NSider Patient Education Tool allows nurses to assemble patient information based on characteristics such as cancer type, stage of treatment and type of treatment, as well as topics of interest such as insurance information, end-of-life care and eating tips. In addition, NSider will offer specific information and tools to help educate patients about the side effects of cancer treatment, such as a downloadable resource for patients to track chemotherapy-induced nausea and vomiting (CINV) and share with their cancer care team during office visits.

Nurses can choose from three different methods when preparing information for their patients: the first method allows users to preview and select pages of content to include in one packet; the second method offers previously-created packets that can be edited as needed; and the third method allows nurses to search through all available pages using key words to find the most useful information for their patients. A video tutorial is available to help users get started. All three methods produce a tailored educational packet that can easily be converted to PDF format and printed or e-mailed to the patient.

“We’re proud to launch the NSider Patient Education Tool, which supports the important relationship and dialogue between patients and nurses,” said Steven C. Sembler, senior vice president of Commercial U.S. Pharmaceuticals at Eisai Inc. “NSider is the latest initiative to underscore Eisai’s commitment to furthering our human health care (hhc) mission of increasing benefits for patients and their families.”

NSider does not promote any particular brand or product. Instead, content focuses on some of the most common cancers, including breast, prostate, lung, colorectal and melanoma. The Web-based program can be accessed from any computer and is free to nurses that register.

Eisai Inc.
Eisai Inc. was established in 1995 and is ranked among the top-20 U.S. pharmaceutical companies (based on retail sales). The company began marketing its first product in the United States in 1997 and has rapidly grown to become a fully integrated pharmaceutical business with fiscal year 2008 (year ended March 31, 2009) sales of approximately $3.7 billion. Eisai’s areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

Eisai has a global product creation organization that includes U.S.-based R&D facilities in Maryland, Massachusetts, New Jersey, North Carolina and Pennsylvania as well as manufacturing facilities in Maryland and North Carolina. The company’s areas of R&D focus include neuroscience; oncology; vascular, inflammatory and immunological reaction; and antibody-based programs. For more information about Eisai, please visit www.eisai.com.

Eisai Co., Ltd.
Eisai Co., Ltd. is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. Eisai employs approximately 11,000 employees worldwide.